Epigenetic Monitoring

For the last 15 years I have tried to get preventive testing into healthcare.
. I have failed . My goal was to provide preventive laboratory testing
that looked at and monitored “abnormal” biochemical chages not associated
with formal disease, i.e., if you already have disease how can your actions
be called preventive.

I am looking for people that agree with me, that insurance and the
government have indireclty limited our knowledge of wellness, by requiring
insurance paymwnts to be linked to a specific disease process ( the
diagnostic CPT code system). To further control medical practice, they have
also label anything that can change a disease process a drug and under
government control.

Concepts of Adaptogenic Medicine as developed by Dr Halstead culminated in
his understanig of how Chinese herbs were used in cancer therapy and other
diseases.

Dr John R Christopher thought me that there is no incurable disease, only
patients that are not doing the right thing.
The current medical system defines any intervention that is effective (at
moderating cancer), that does not have a known biochemical pathway as a
spontaneous remission or misdiagnosis.

The fact that there are a myriad of factors that produce epigenetic
biochemical changes is forcing the medical profession to expand its
description of “what can produce a health benefit”. We can use
epigenetic biochemical change monitoring to validate an intervention for
Hepatitis C or drug liver toxicity in less than 30 days by monitoring a shift
in protein distribution. Many possible effective treatments are not started
or are stopped because the patient and physician could not determine if the
“intervention works”. Many indigenous healing herbs are unused due to
lack of knowledge of their effectiveness.

In 2006 I provided the FDA with information, based on 1970's laboratory
testing methods that showed for $40 you can get better information on a
drug's toxicity effect on a specific individual than anythig being done
today. Their respone was this is not in there scope of work. i.e."They only
want to know who might be at risk for a transplant."

I would like to discuss the use of new laboratory tests and other
non-invassive patient monitoring mentods. Specifically, how they could
support new treatment interventions. Epigenetic biochemical monitoring of
changes over time is superior to current laboratory methods.

George Morris

Posted Answers

A:


 Answer by prokopton

Share this with your friends